Clinical cardiology + vascular Flashcards
Inotropes
Increase cardiac contractility in order to increase cardiac output (CO) e.g. in cardiac arrest, cardiogenic shock.
Adrenaline
- beta-1 = increases contractility and HR
- 0.05mcg/kg/min.
- At higher doses alpha-1 activity predominates -> vasoconstriction -> end-organ ischaemia
Dobutamine
- in doses of 5- 10mcg/kg/min
- higher doses have more vasopressor effect
Isoprenaline
Milrinone
- Purely inotropic
- Phosphodiesterase inhibitor
- Does not cause tachycardia
Vasopressors
Induce vasoconstriction in order to increase PVR
- e.g. sepsis, hypovolaemia
- Increases the heart’s oxygen demand so risk of angina/ischaemia
Noradrenaline
- alpha-1 = vasoconstriction
- Can combine with dobutamine, milrinone etc.
- Risk of reflex bradycardia and peripheral ischaemia
- 0.05mcg/kg/min
Vasopressin
- VR1 = vasoconstriction.
Phenylephrine
Mean arterial pressure
Aim 65 mmHg
If older, more likely to have atherosclerosis and HTN with chronic adaptation so aim higher e.g. 75-85 mmHg
Too low = hypoperfusion
Too high = ischaemic injury
HFrEF - management
1st line
- Symptomatic
- Loop diuretic
- Prognostic
- ACEi/ARB
- Aldosterone antagnist
- SGLT2 inhibitor
- Other
- Lifestyle advice
- Pneumococcal + influenza vaccines
2nd line with LVEF < 35%
- Switch to sacubitril/valsartan
- If QRS > 120ms, CRT-P/D
- If HR > 75 but sinus, ivabradine
- African-American, hydralazine
3rd line:
- LVAD
- Heart transplant
- Palliative support
Cardiac resynchronisation therapy (CRT)
Indications:
- Heart failure with broad QRS
- Evidence of dyssynchronous activity of the
ventricles
- May signify a level of BBB
- Dyssynchrony impairs the ventricular function
Technique:
- RA + RV + LV leads
- Paces almost all the time for maximum LV function
- Set at a higher than normal rate + patient beta-
blocked
CRT-P
- Biventricular pacemaker to synchronise the ventricles
CRT-D
- Biventricular pacemaker with added defibrillation activity
NYHA functional classification
Class I
- No limitation in physical activity
- No symptoms with ordinary physical activity
Class II
- Slight limitation in physical activity
- Symptomatic with ordinary physical activity
- Asymptomatic at rest
Class III
- Marked limitation in physical activity
- Asymptomatic at rest
- Symptomatic with less than ordinary physical activity
Class IV
- Symptomatic at rest
- Unable to complete personal care without severe symptoms
HFpEF - management
Control BP, heart rate, arrhythmias
Symptomatic support with loop diuretics
ACEi/ARB/ARNI
MRA
SGLT2 inhibitor
Pulsus alternans
When an arterial pulse alternates between strong and weak beats
L-sided = heart failure, AS, cardiomyopathy
R-sided = PE, pulmonary HTN
Acute heart failure aetiology
ACS
Hypertensive crisis
Arrhythmia
PE
Infection/inflammation
Tamponade
Mechanical
- Free wall rupture
- Acute MR
- Chest trauma
- Infective endocarditis
- Aortic dissection
Acute heart failure - the four presentations and management
- Acute decompensation/congestion
- Onset over days
- IV loop diuretics +/- metolozone - Acute pulmonary oedema
- IV loop diuretics
- High-flow oxygen +/- CPAP - Isolated RV failure
- More gentle diuresis + I/O monitoring possible - Cardiogenic shock
- Inotropes
- If not responding, consider vasopressors and acute RRT
HFrEF - causes
Defined as LVEF < 40%
MI
Dilated cardiomyopathy
Myocarditis
Valvular heart disease
HFpEF - causes
Clinical heart failures with LVEF > 40%
HTN
LVH
HOCM
Amyloidosis/sarcoidosis
Valvular heart disease
Hypertrophic cardiomyopathy - causes
HOCM
Friederich’s ataxia
Fabry disease
Dilated cardiomyopathy - causes
Alcohol
Myocardial damage e.g. post-MI or post-myocarditis
Pregnancy
Chagas disease
TB
Infiltrative disease e.g. amyloidosis
Thiamine deficiency
Genetic
Restrictive cardiomyopathy
Genetic
Amyloid
Sarcoid
Scleroderma
Hereditary haemochromatosis
Takotsubo cardiomyopathy
Stress-induced, ?SNS overdrive
ECG changes + trop rise with normal angiogram
Echo - apical hypokinesis
CT angio - no lesions
Mx - diuretics, ACEi, beta-blockers
Peripartum cardiomyopathy
Defined as new clinical heart failure occurring towards the ends of, or up to 5 months after, pregnancy.
Usually presents as reduced LVEF with no other cause found
Stable - vaginal delivery
Unstable - emergency C-section
Variable recovery, up to 70% within 6 months
Pacemarker-induced cardiomyopathy
Defined as a reduction in LVEF > 10% following PPM placement
Develops in 1/8 of people receiving a PPM for complete heart block with normal LVEF.
More common with isolated R-sided pacing due to dyssynchronous contraction
Mx - upgrade to CRT
Clubbing - aetiology
Lung:
- Cancer - esp. NSCLC, mesothelioma
- ILD
- Complicated TB
- Suppurative lung disease e.g. abscess, empyema, bronchiectasis, cystic fibrosis
- Sarcoidosis
Heart:
- Congenital cyanotic heart disease
- Subacute infective endocarditis
- Atrial myxoma
GI:
- Malabsorption
- IBD
- Cirrhosis incl. PBC
Other:
- Grave’s disease
Aortic stenosis - causes and presentation
Occurs in 2% of over-65s
Causes
- Age-related calcification
- Rheumatic fever
- Paget’s disease of the bone
- Bicuspid aortic valve (1-2% of live births)
Signs:
- Slow-rising pulse
- Narrow pulse pressure
- Ejection systolic murmur with radiation
- +/- clinical heart failure
Aortic stenosis - management
Medical
- Beta-blockers
- Diuresis
Surgical
- TAVI
- Surgical valve replacement
Uses metallic valve if age < 65 or biologic if > 65
- Metallic valves must be anticoagulated with warfarin but have a longer life-time
Aortic stenosis surgical criteria
Symptomatic low-flow AS
Asymptomatic severe
- Vmax (peak aortic jet velocity) more than 5 m/s
- Aortic valve area less than 0.6 cm2
- LVEF (left ventricular ejection fraction) less than 60% y
- BNP/NT-proBNP level more than twice the upper limit of normal
- symptoms unmasked on exercise testing.
Mitral regurgitation - causes and presentation
Causes:
- Acute - MI, trauma, endocarditis
- Chronic - age-related, rheumatic fever
Signs:
- Irregularly irregular pulse
- Systolic thrill at apex
- Pansystolic murmur with radiation to axilla
Mitral regurgitation - management
Medical - anticoagulation if concurrent AF
Surgical = valve repair
- LVEF < 60%
- ESDI more than 2.2 cm/m2
- Increase of systolic pulmonary artery pressure to more than 60 mgHg on exercise testing
33% survival at 8 years without surgery
Death usually due to heart failure but can be sudden secondary to arrhythmia